HOME › DRUGS › TEMSIROLIMUS
ACTIVE SUBSTANCE / INN

TEMSIROLIMUS

Brand name(s): TEMSIROLIMUS, TORISEL, Torisel
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
Carcinoma, Renal Cell;Lymphoma, Mantle-Cell
ANDA203153
ACTIVE SUBSTANCE
Temsirolimus
REGULATORS
FDA · EMA
SPONSORS / MAH
ACCORD HLTHCARE, PF PRISM CV, Pfizer Europe MA EEIG
TOTAL APPLICATIONS
3
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
TEMSIROLIMUSANDA203153ACCORD HLTHCAREPrescription
TORISELNDA022088PF PRISM CVPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
ToriselPfizer Europe MA EEIGAuthorised19/11/2007Carcinoma, Renal Cell;Lymphoma, Mantle-Cell

FULL INTELLIGENCE ON TEMSIROLIMUS

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →